CNE0000017M1
CNE0000017M1
KANGMEI PHARMACEUTICAL CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.252.215.058 | 5.189.137.200 | 1.2% |
| Cost of Revenue | 4.203.085.987 | 4.422.148.258 | 5.0% |
| Gross Profit | 1.049.129.071 | 766.988.942 | 36.8% |
| 937.446.315 | 741.374.880 | 26.4% | |
| Operating Income | 111.682.756 | 25.614.062 | 336.0% |
| Pretax Income | 43.115.914 | 34.650.440 | 24.4% |
| Net Income Common Stockholders | 10.327.998 | 8.573.663 | 20.5% |
| -- | -- | -- | |
| -- | -- | -- |